IL4 and COVID-19: Thus, we speculate that the persistent high levels of IL-4 reported during SARS-CoV-2 infection and in the post-acute phase [29,141] are responsible for the downregulation of the 5-LOX protein in COVID-19 and long-COVID patients, compared with healthy donors (Figure 3A,B).